Mizuno, M., Kuno, A., Yano, T., Miki, T., Oshima, H., Sato, T., . . . Miura, T. (2018). Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts. Physiol Rep.
Citación estilo ChicagoMizuno, Masashi, et al. "Empagliflozin Normalizes the Size and Number of Mitochondria and Prevents Reduction in Mitochondrial Size After Myocardial Infarction in Diabetic Hearts." Physiol Rep 2018.
Cita MLAMizuno, Masashi, et al. "Empagliflozin Normalizes the Size and Number of Mitochondria and Prevents Reduction in Mitochondrial Size After Myocardial Infarction in Diabetic Hearts." Physiol Rep 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.